Retrospective Evaluation of Thromboembolism Risk in Ovarian Cancer Patients Treated with Bevacizumab

Anna Kuk,Magdalena Magnowska,Wiktor Suchy,Joanna Swierczynska,Mikolaj Zaborowski,Gaca M,Nowak-Markwitz E

Retrospective Evaluation of Thromboembolism Risk in Ovarian Cancer Patients Treated with Bevacizumab

2017

Anna Kuk
Magdalena Magnowska
Wiktor Suchy
Joanna Swierczynska
Mikolaj Zaborowski
Gaca M
Nowak-Markwitz E

Background Bevacizumab is used in addition to standard, platinum-based chemotherapy to treat advanced-stage ovarian cancer patients. Thrombosis is a well-documented adverse effect of bevacizumab.

Keywords:

Bevacizumab
Urology
Ovarian cancer
Immunology
Medicine
Chemotherapy
Adverse effect
Gynecology
Thrombosis
Oncology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations